Response and Adherence to Nilotinib in Daily Practice
Latest Information Update: 01 Aug 2021
At a glance
- Drugs Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms RAND
- 02 Jun 2020 Results published in the European Journal of Clinical Pharmacology
- 25 Aug 2014 According to Netherlands Trial Registry record, Status changed from not yet recruiting to recruiting.
- 28 May 2013 New trial record